| Summary: | Amjad Bani Hani,1 Nour Awamleh,2 Shahd Mansour,2 Ahmad A Toubasi,2 Moaath AlSmady,1 Mutaz Abbad,1 Mohammad Banifawaz,1 Mahmoud Abu Abeeleh1 1Department of General Surgery, Division of Cardiac Surgery, The University of Jordan, Amman, 11942, Jordan; 2School of Medicine, The University of Jordan, Amman, 11942, JordanCorrespondence: Shahd Mansour, School of Medicine, The University of Jordan, PO Box 13046, Amman, 11942, Jordan, Tel +962 6 5355000, Email mansourshahd00@gmail.comBackground: Valvular heart disease (VHD) has a significant prevalence and mortality rate with surgical intervention continuing to be a cornerstone of therapy. We aim to report the outcome of patients undergoing heart valve surgery (HVS) in a low-volume center (LVC) in a low- and middle-income country (LMIC).Methods: A cross-sectional retrospective study was conducted at the Jordan University Hospital (JUH), a tertiary teaching hospital in a developing country, between April 2014 and December 2019. Patients who underwent mitral valve replacement (MVR), aortic valve replacement (AVR), tricuspid valve replacement (TVR), double valve replacement (DVR), CABG + MVR, and CABG + AVR patients were included. Thirty-day and two-year mortalities were taken as the primary and secondary outcomes, respectively.Results: A total number of 122 patients were included, and the mean age was 54.46 ± 14.89 years. AVR was most common (42.6%). There was no significant association between STS mortality score or Euroscore II with 30-day and 2-year mortality.Conclusion: LVC will continue to have a role in LMICs, especially during development to HICs. Further global studies are needed to assert the safety of HVS in LVC and LMICs.Keywords: valve surgery, low-volume center, low- and middle-income country
|
|---|